Impact of COVID-19 Pandemic on Advanced Non-small Cell Lung Cancer Treatment at a Japanese Hospital.

Miyazaki, Kunihiko; Kodama, Takahide; Aida, Yuka; Sato, Shinya; Satoh, Hiroaki

Miyazaki, Kunihiko; Kodama, Takahide; Aida, Yuka; Sato, Shinya; Satoh, Hiroaki.

Afiliación

Miyazaki K; Division of Respiratory Medicine, Ryugasaki Saiseikai Hospital, Ryugasaki, Japan.
Kodama T; Division of Respiratory Medicine, Ryugasaki Saiseikai Hospital, Ryugasaki, Japan.
Aida Y; Division of Respiratory Medicine, Faculty of Clinical Medicine, University of Tsukuba, Tsukuba, Japan.
Sato S; Division of Medical Oncology, Faculty of Clinical Medicine, University of Tsukuba, Tsukuba, Japan.
Satoh H; Division of Respiratory Medicine, Ryugasaki Saiseikai Hospital, Ryugasaki, Japan.

Cancer Diagn Progn ; 3(6): 716-720, 2023.

Article en En | MEDLINE | ID: mdl-37927803

Palabras clave

COVID-19; Non-small cell lung cancer; delayed diagnosis; delayed treatment

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Cancer Diagn Progn Año: 2023 Tipo del documento: Article País de afiliación: Japón